Trial Outcomes
thrombosis, death, bleeding, target-vessel, stroke
THROMBOSIS, MYOCARDIAL INFARCTION (MI), BLEEDING, CARDIAC EVENTS, STROKE, EVENTS
All outcomes were adjudicated by a committee of members who were unaware of trial-group assignments. The primary outcome was the composite of death from cardiac causes, myocardial infarction (MI), or definite or probable stent thrombosis at 1 year. Secondary outcomes included the components of the primary outcome, major adverse cardiac and cerebrovascular events (defined as death, MI, or stroke), major adverse cardiac events (defined as death, MI, or target-vessel revascularization), stroke, target-vessel or lesion failure, and bleeding events. MI was primarily defined according to the Academic Research Consortium–2 definition.